Spyre Therapeutics, Inc.
SYRE
$44.07
$4.1810.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.44% | 17.37% | 23.61% | 16.54% | 77.76% |
| Total Receivables | -- | 288.24% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 238.80% | 129.15% | -10.15% | -41.19% | 139.27% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 27.82% | 19.84% | 23.66% | 16.93% | 78.16% |
|
|
|||||
| Total Current Assets | 27.82% | 19.84% | 23.66% | 16.93% | 78.16% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -96.96% | -96.98% |
| Total Assets | 27.82% | 19.83% | 23.57% | 16.85% | 77.99% |
|
|
|||||
| Total Accounts Payable | 1,236.94% | 44.38% | 14.89% | 18.77% | -25.67% |
| Total Accrued Expenses | -1.98% | 62.61% | 106.93% | -41.73% | -6.49% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -11.77% | -60.26% | 530.32% | 1,651.27% | 1,288.92% |
| Total Other Current Liabilities | -11.77% | -60.26% | 530.32% | 1,651.27% | 1,288.92% |
| Total Current Liabilities | 8.56% | -19.58% | 275.46% | 65.07% | 69.05% |
|
|
|||||
| Total Current Liabilities | 8.56% | -19.58% | 275.46% | 65.07% | 69.05% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -89.46% | -91.07% | -- | -94.36% | -70.91% |
| Total Liabilities | -31.03% | -47.17% | 34.66% | -74.01% | -42.55% |
|
|
|||||
| Common Stock & APIC | 26.38% | 25.53% | 26.94% | 73.11% | 74.82% |
| Retained Earnings | -15.96% | -16.26% | -24.41% | -25.85% | -27.21% |
| Treasury Stock & Other | 382.78% | -45.71% | 182.10% | 287.88% | -40.40% |
| Total Common Equity | 54.54% | 74.44% | 37.24% | 1,100.64% | 39,834.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | -15.74% | -15.74% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | -15.74% | -15.74% |
|
|
|||||
| Total Common Equity | 54.54% | 74.44% | 37.24% | 1,100.64% | 39,834.80% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | -15.74% | -15.74% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 38.13% | 39.01% | 21.74% | 216.95% | 181.39% |
|
|
|||||